{"id":424323,"date":"2025-12-04T15:11:13","date_gmt":"2025-12-04T15:11:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/424323\/"},"modified":"2025-12-04T15:11:13","modified_gmt":"2025-12-04T15:11:13","slug":"say-goodbye-to-your-driving-licence-if-youre-over-65-and-take-these-medications-in-spain","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/424323\/","title":{"rendered":"Say goodbye to your driving licence if you’re over 65 and take these medications in Spain"},"content":{"rendered":"

Road safety debates have resurfaced as new measures target drivers aged over 65 who take certain medications. While Spain doesn’t impose an age limit for driving, licence renewal procedures<\/strong> have become more stringent for this demographic, especially when medications that significantly affect driving abilities are involved.<\/p>\n

Medical reviews and monitoring have intensified for older drivers to minimise risks and promote safer roads. It’s worth noting that those over 65 must now renew their driving licences<\/a> every five years<\/strong> rather than every ten, increasing the frequency of physical and mental fitness assessments.<\/p>\n

Medications that impact driving ability<\/p>\n

In recent months, authorities have focused on how certain medications affect driving performance. Among the primary concerning pharmaceuticals are anxiolytics and antidepressants<\/strong>, known for causing drowsiness and slowing reflexes. Antihistamines<\/strong>, commonly used for allergies, also feature prominently on watchlists due to their sedative effects.<\/p>\n

The challenges extend beyond these medications. Opioids and powerful painkillers<\/strong> impair concentration and reaction time, proving particularly hazardous on the road. Additionally, insulin treatment for diabetic drivers<\/strong> can trigger hypoglycaemic episodes, causing dizziness or even consciousness loss\u2014factors wholly incompatible with safe driving.<\/p>\n

Another critical concern involves medications for sleep apnoea.<\/strong> Licence renewal now requires a medical report confirming treatment effectiveness, without which driving authorisation may be denied.<\/p>\n

Medical conditions incompatible with safe driving<\/p>\n

Beyond medication concerns, various medical conditions can affect obtaining or renewing a driving licence. Neurological disorders such as epilepsy<\/strong> and recent episodes of consciousness loss significantly compromise road safety.<\/p>\n

Cardiovascular conditions<\/strong> including arrhythmias or recent heart attacks are considered incompatible with driving due to the risk of sudden emergencies behind the wheel. Similarly, poorly controlled insulin-dependent diabetes and untreated sleep apnoea commonly lead to licence denial, given their direct impact on attention and alertness.<\/p>\n

In the psychiatric realm, conditions such as dementia, schizophrenia, or bipolar disorder<\/strong> may render drivers a risk to themselves and other road users due to impaired judgment and reaction capabilities.<\/p>\n

Assessment requirements for senior drivers<\/p>\n

To comply with these regulations, drivers over 65 must undergo periodic medical evaluations. The assessment protocol includes detailed reports on physical and mental fitness<\/strong> that must be submitted for licence renewal. Without proper certification, the DGT<\/a> is authorised to refuse renewal applications.<\/p>\n

Healthcare professionals advise patients to thoroughly consult with their GP<\/strong> when prescribed medications that might affect driving. This consultation helps assess the risks of continuing to drive and, if necessary, adjust treatment or implement preventive measures.<\/p>\n

Up-to-date and comprehensive medical reports not only protect drivers<\/strong> from potential penalties and risks but also contribute to collective road safety across Spanish roads.<\/p>\n","protected":false},"excerpt":{"rendered":"Road safety debates have resurfaced as new measures target drivers aged over 65 who take certain medications. While…\n","protected":false},"author":3,"featured_media":424324,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[197825,197826,197832,197827,197828,197829,210,197830,1060,197831,67,132,68],"class_list":{"0":"post-424323","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-dgt","9":"tag-dgt-in-spain","10":"tag-did-you-know","11":"tag-driving-in-mallorca","12":"tag-driving-in-spain","13":"tag-driving-licences","14":"tag-health","15":"tag-mallorca-driving-licences","16":"tag-medication","17":"tag-spain-roads","18":"tag-united-states","19":"tag-unitedstates","20":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115661942969448488","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/424323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=424323"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/424323\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/424324"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=424323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=424323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=424323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}